What are the available payment terms?

We accept LC, T/T, D/P, PayPal, Western Union, and small-amount payments.

For what conditions is Mycophenolate Mofetil used?

It is used for organ transplantation, autoimmune diseases like lupus nephritis, and preventing graft-versus-host disease.

What is the physical appearance of the powder?

The product appears as a white powder.

Factory 99% Mycophenolate Mofetil Powder CAS 115007-34-6 Mycophenolate Mofetil

Name: Factory 99% Mycophenolate Mofetil Powder CAS 115007-34-6 Mycophenolate Mofetil
Brand: Xi'an Xinlu Biotechnology Co., Ltd.
SKU: 2072324292

Shaanxi, ChinaXi'an Xinlu Biotechnology Co., Ltd.

US$10.00-20.00

1 g

Sample price:US$20.00/g.Request sample

Product profile

Customization

Available

Powder

Yes

Customized

Model NO.

A624

Certification

GMP, HSE, ISO 9001, USP, BP

Suitable for

Elderly, Children, Adult

State

Powder

Purity

>99%

Name

Mycophenolate Mofetil

CAS

115007-34-6

Appearance

White Powder

Assay

99%

OEM

Available

Sample

Available

Suitable

Adult

MOQ

Function

Immunosuppression

Transport Package

Foil Bag

Specification

Trademark

Origin

China

Production Capacity

10000 Kgs Per Month

Key features

High Purity Grade: Purity exceeds 99% with white powder appearance.

Multiple Certifications: Certified by GMP, HSE, ISO 9001, USP, and BP standards.

OEM and ODM Services: Full customization, design, and sample-based customization available.

Broad Application Scope: Suitable for elderly, children, and adults for various medical needs.

Organ Transplant Support: Cornerstone therapy for kidney, heart, liver, and lung transplants.

Autoimmune Disease Treatment: Effective for lupus nephritis and specific types of vasculitis.

GVHD Prevention: Used to prevent graft-versus-host disease in stem cell transplants.

Improved Patient Outcomes: Associated with better survival rates and reduced disease activity.

Company profile

In-stock CapacityFast DeliveryOEM ServicesR&D Capabilities

Xi'an Xinlu Biotechnology Co., Ltd.

Shaanxi, China

Business Type: Manufacturer/Factory CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 5 years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤1.64h

AI-Powered supplier vetting

SummaryXi'an Xinlu Biotechnology Co., Ltd. was established in 2015 and specializes in the R&D, production, processing, and sales of natural plant extracts and pharmaceutical intermediates. Its stated product range includes Matrine, Oxymatrine, Magnolol, Honokiol, Gentiopicroside, Cytisine, and other compounds. The supplier reports OEM service for well-known brands, in-stock capability, broad customization options, and export activity accounting for 51%–70% of total sales. However, it reports no available SDK, no overseas warehouse, showroom, agents, branches, or offline trade-show participation. Quality-system evidence is weak: there are no written corrective-action or complaint-handling procedures, and quality-control testing equipment is reported as zero. Certification, raw-material traceability, environmental documentation, fire-drill practices, and manufacturing-contract status remain unverified.

Supplier typeThe supplier is a biotechnology company focused on the R&D, production, processing, and sales of natural plant extracts and pharmaceutical intermediates. Its permitted business scope also includes pre-packaged food, non-food health products, and import/export activities, indicating a manufacturer and trading-capable supplier rather than a purely service-based company.

After-Sales capabilityThe supplier reports in-stock service capability and accepts FOB, CIF, CFR, and EXW quotation terms. Nevertheless, it has no overseas warehouse, showroom, agents, or branches, and reports no written procedures or records for customer complaint handling or corrective and preventive actions, which is a stated service-process deficiency.

R&D capabilityThe supplier describes itself as having R&D capability, offers customized product development, and can cooperate with customers to develop new products. However, it explicitly reports no available SDK, so software-development integration capability is absent; overall innovation strength is only partially evidenced.

Production capacityThe supplier describes production and processing capabilities, lists multiple plant-derived compounds, operates from a site of about 10,000 square meters, and reports inventory capability. However, manufacturing-contract status is unknown and the quality-control section reports zero testing equipment, creating a material concern about documented production-control capability.

Customization capabilityThe supplier explicitly supports customization from samples, designs, full customization, minor customization, and flexible customization. It also states that it can produce according to customer needs and cooperate in developing new products, providing direct evidence of broad customization capability.